Skip to content

Evaluating the efficacy of rTMS in managing somatosensory deficits post ischemic stroke: a randomised and sham-controlled study

Evaluating the efficacy of rTMS in managing somatosensory deficits post ischemic stroke: a randomised and sham-controlled study

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200059098
Enrollment
Unknown
Registered
2022-04-24
Start date
2022-04-11
Completion date
Unknown
Last updated
2024-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

somatosensory deficits post stroke

Interventions

10 Hz:10 Hz rTMS over lesioned S1
1 Hz:1 Hz rTMS over ipsilateral S1

Sponsors

Centre for Cognition and Brain Disorders, Hangzhou Normal University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: a. unilateral ischemic stroke. b. somatosensory deficits caused by ischemic stroke c. 18-80 years old. d. regular stroke medicines. e. rTMS illegible f. capable of fulfilling assessments

Exclusion criteria

Exclusion criteria: Exclusion criteria: a. not able to receive rTMS. b. severe mental disorders: HAMD = 35 or HAMA = 29. c. aphasia or cognitive disorders: MMSE = 24. d. not able to fulfil assessments e. severe disorders caused by others, e.g. tumour. f. mRS > 2. g. severe heart or lung misfunctioning or extremely weak h. somatosensory deficits not caused by ischemic stroke, e.g. diabetes pain

Design outcomes

Primary

MeasureTime frame
Fugl-Meyer and Lindmark Assessment;

Countries

China

Contacts

Public ContactXianwei Che

Affiliated Hospital of Hangzhou Normal University

xwcheswu@gmail.com+86 18072852895

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 5, 2026